• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agency of Health Technology Assessment of Uruguay
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Healthcare Quality Institute
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [24726 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2007     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Rapid versus full systematic reviews: an inventory of current methods and practice in Health Technology Assessment. Report no 60
2014     NIHR Horizon Scanning Centre (NIHR HSC) RAPIDEC® CARBA NP test for confirmation or detection of Carbapenemase producing bacteria
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rarunavir/cobicistat (Rezolsta®)
2014     Medical Services Advisory Committee (MSAC) RAS (Kirsten RAS and Neuroblastoma RAS) mutation testing for eligibility for panitumumab treatment in previously untreated metastatic colorectal cancer patients.
2004     University HealthSystem Consortium (UHC) Rasagiline
2006     HAYES, Inc. Rasagiline for treatment of Parkinson's disease
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Rasburicase and hyperuricemia in cancer patients
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Rasburicase for adults with acute tumor lysis syndrome: a review of clinical and cost effectiveness and safety
2005     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Rate control versus serial electric cardioversion forchronic atrial fibrillation - primary research
2023     NIHR Health Technology Assessment programme Rates of medical or surgical treatment for women with heavy menstrual bleeding: the ECLIPSE trial 10-year observational follow-up study
2003     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Rational antibiotic utilisation in selected paediatric conditions
2003     Malaysian Health Technology Assessment Unit (MHTAU) Rational antibiotic utilisation in selected paediatric conditions
2005     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Rational use of analgesics in paediatrics
2006     Malaysian Health Technology Assessment Unit (MHTAU) Rational use of analgesics in paediatrics
1999     Unidad De Tecnologias De Salud (ETESA) Rational use of colloid solutions. Part I
2008     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rational vaccination policies - decision support. Review of international literature for "rational" vaccination policies
2021     Scottish Medicines Consortium (SMC) Ravulizumab for the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH): in patients with haemolysis with clinical symptom(s) indicative of high disease activity; in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months
2023     National Institute for Health and Care Excellence (NICE) Ravulizumab for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder (terminated appraisal). NICE technology appraisal guidance 941
2021     National Institute for Health and Care Excellence (NICE) Ravulizumab for treating atypical haemolytic uraemic syndrome. NICE technology appraisal guidance 710
2023     National Institute for Health and Care Excellence (NICE) Ravulizumab for treating generalised myasthenia gravis (terminated appraisal). NICE technology appraisal guidance 940
2021     National Institute for Health and Care Excellence (NICE) Ravulizumab for treating paroxysmal nocturnal haemoglobinuria. NICE technology appraisal guidance 698
2022     NIHR Health Technology Assessment programme RCT of clinical and cost-effectiveness of drug coated balloons, drug eluting stents and balloon angioplasty with bail-out bare metal stent revascularisation strategies for severe limb ischaemia due to femoro-popliteal disease: BASIL-3 (Balloon vs Stenting in Severe Ischaemia of the Leg)
2008     University of York RCTs for policy interventions? A review of reviews and meta-regression - systematic review
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Re-orientation of the Austrian parent-child preventive care programme: from assessment to expert appraisal
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Re-orientation of the Austrian parent-child preventive care programme. Part XI: Further development of the mother-child-pass: Screening recommendations of the expert working group for pregnancy, puerperium and early childhood (0-6 years)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
1996     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Re-use of medical devices
2017     NIHR Health Services and Delivery Research programme REACH: a mixed-methods study to investigate the measurement, prediction and improvement of retention and engagement in outpatient HIV care
2016     NIHR Horizon Scanning Centre (NIHR HSC) ReActiv8® implantable device for treating chronic low back pain
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Real-time (synchronous) telehealth in primary care: systematic review of systematic reviews
2014     Andalusian Health Technology Assessment Area (AETSA) Real-time 3D Transesophageal Echocardiography (RT-3D-TEE) versus 2D.
2009     Medical Services Advisory Committee (MSAC) Real-time measurement of cardiac output and other cardiac flow parameters (without concurrent cardiac imaging) using continuous wave Doppler techniques
2017     NIHR Health Technology Assessment programme Real-time modelling of a pandemic influenza outbreak
2024     NIHR Health and Social Care Delivery Program Real-time ultrasound elastography in the diagnosis of newly identified thyroid nodules in adults: the ElaTION RCT
2021     Center for Drug Evaluation (CDE) Real-world results of immune checkpoint inhibitors from the Taiwan National Health Insurance Registration System
2011     NIHR Horizon Scanning Centre (NIHR HSC) RealTime mS9 Colorectal Cancer (CRC) assay for the early detection of colorectal cancer
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Reassessment of health technologies: obsolescence and waste
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Rebetron - hepatitis C
2025     NIHR Health Technology Assessment programme Recent research in myalgic encephalomyelitis/chronic fatigue syndrome: an evidence map
1994     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Receptor-imaging somatotropine inhibitor factor analogue in endocrine oncology - primary research
2009     HAYES, Inc. Reclast (Novartis Pharmaceuticals Corp.) for bone loss prevention during breast cancer chemotherapy
2015     University of York Recognising and managing frailty in primary care
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant activated factor VII for prevention of bleeding unrelated to hemophilia: clinical and economic systematic review
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant activated Factor VII in treatment of hemorrhage unrelated to hemophilia: a systematic review and economic evaluation
2002     University HealthSystem Consortium (UHC) Recombinant antihemophilic factor VIII
2022     Agency for Care Effectiveness (ACE) Recombinant blood products for prophylaxis and management of haemophilia A and B
2010     Penn Medicine Center for Evidence-based Practice (CEP) Recombinant coagulation factor VIIa (rFVIIa) for treatment of bleeding and transient normalization of inr in patients on warfarin anticoagulation
2004     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa (NovoSeven) for life-threatening surgical and traumatic bleeding in non-haemophiliacs - horizon scanning review
2003     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa (NovoSeven) for life-threatening surgical and traumatic bleeding in non-haemophiliacs - horizon scanning review
2003     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa (NovoSeven) for prevention and treatment of bleeding in patients with underlying disease - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa (NovoSeven) in intracerebral haemorrhage (ICH) - horizon scanning review
2009     Penn Medicine Center for Evidence-based Practice (CEP) Recombinant factor VIIa for cardiovascular surgery
2002     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa in haemostatis - horizon scanning review
2002     HAYES, Inc. Recombinant growth hormone treatment for AIDS/HIV-associated wasting and lipodystrophy
2012     HAYES, Inc. Recombinant growth hormone treatment for AIDS/HIV-associated wasting and lipodystrophy
2003     HAYES, Inc. Recombinant growth hormone treatment for burns, surgery, and critical illness
2003     HAYES, Inc. Recombinant growth hormone treatment for obesity
2003     HAYES, Inc. Recombinant growth hormone treatment in children
2002     HAYES, Inc. Recombinant growth hormone treatment in growth hormone-deficient adults
2014     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant human alpha-mannosidase (Lamazym) for alpha mannosidosis
2014     HAYES, Inc. Recombinant human bone morphogenetic protein (rhBMP) for use in spinal fusion
2004     HAYES, Inc. Recombinant human bone morphogenetic protein for use in bone repair
2006     HAYES, Inc. Recombinant human bone morphogenetic protein for use in spinal fusion
2011     HAYES, Inc. Recombinant human bone morphogenetic protein for use in spinal fusion
2006     HAYES, Inc. Recombinant human bone morphogenetic protein for use in tibia repair
2011     HAYES, Inc. Recombinant human bone morphogenetic protein for use in tibia repair
2001     Blue Cross Blue Shield Association (BCBS) Recombinant human growth hormone (GH) therapy in adults with age-related GH deficiency
1998     ECRI Recombinant human growth hormone for AIDS wasting
2010     NIHR Health Technology Assessment programme Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation
2000     ECRI Recombinant human growth hormone for the treatment of idiopathic short stature
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant human growth hormone for treatment of Turner Syndrome: systematic review and economic evaluation
2013     HAYES, Inc. Recombinant human growth hormone treatment in children under 2 years of age
2012     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) for mucopolysaccharidosis type IVA – first line
2005     ECRI Recombinant human osteogenic protein-1 [rhOP-1] for healing nonunion fractures of the tibia
2020     National Institute for Health and Care Excellence (NICE) Recombinant human parathyroid hormone for treating hypoparathyroidism (terminated appraisal). NICE technology appraisal guidance 625
2002     Medical Services Advisory Committee (MSAC) Recombinant human thyroid-stimulating hormone (rhTSH). Diagnostic agent for use in well-differentiated thyroid cancer
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Recombinant tissue plasminogen activator (rt-PA) in acute ischemic stroke
2024     Agency for Care Effectiveness (ACE) Recombinant zoster vaccine for the prevention of herpes zoster and post-herpetic neuralgia
2000     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Recombinant-FSH as adjuvant in assisted reproduction: some data on the efficacy and efficiency of recombinant-FSH related to FSH of urinary origin
2006     Institute for Clinical Evaluative Sciences (ICES) Recommendations for establishing a citizens' council to guide drug policy in Ontario
1997     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Recommendations for medical record of the home care patients for ambulatory nursing professionals
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Recommendations for the use of troponin assays for rapid diagnosis of acute coronary syndrome in the emergency department
2012     Penn Medicine Center for Evidence-based Practice (CEP) Reconciliation of data from differing electronic medical records
1999     Health Council of the Netherlands Gezondheidsraad (GR) Reconsidering the policy for HIV testing
2007     NIHR Health Technology Assessment programme Recruitment to randomised trials: strategies for trial enrolment and participation study. The STEPS study
2017     The Regional Health Technology Assessment Centre (HTA-centrum) Rectal cancer with complete clinical remission after chemoradiotherapy: resection or watch-and-wait?
2025     NIHR Health Technology Assessment programme RecUrrent Intra-articular Corticosteroid injections in Osteoarthritis: the RUbICOn mixed-methods study
2012     Agency for Healthcare Research and Quality (AHRQ) Recurrent nephrolithiasis in adults: comparative effectiveness of preventive medical strategies
1993     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Red blood cell transfusion - consensus conference
1997     University HealthSystem Consortium (UHC) Red blood cell transfusion guidelines
2025     WorkSafeBC Red light therapy for Achilles / other tendon rupture
2003     NIHR Health Technology Assessment programme Redesigning postnatal care: a randomised controlled trial of protocol-based midwifery-led care focused on individual women's physical and psychological health needs
2014     NIHR Horizon Scanning Centre (NIHR HSC) Reducer stent for refractory angina
2013     NIHR Public Health Research (PHR) programme Reducing alcohol-related harm in disadvantaged men: development and feasibility assessment of a brief intervention delivered by mobile telephone
2012     Penn Medicine Center for Evidence-based Practice (CEP) Reducing AMI readmissions
2021     NIHR Health Technology Assessment programme Reducing bias in trials from reactions to measurement: the MERIT study including developmental work and expert workshop
2014     NIHR Health Services and Delivery Research programme Reducing Care Utilisation through Self-management Interventions (RECURSIVE): a systematic review and meta-analysis
2024     NIHR Health Services and Delivery Research programme Reducing health inequalities through general practice: a realist review and action framework